Breast Medical Oncologist at Cleveland Clinic Taussig Cancer Institute, Megan Kruse, MD, joins the Cancer Advances podcast to discuss the differences in the clinical management of invasive lobular breast cancer (ILC) and invasive ductal breast cancer (IDC). Listen as Dr. Kruse discusses the challenges of diagnosing, re-evaluating treatment options, and using genomic data to see different trends for lobular and ductal breast cancer.